Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma

被引：3
|
作者：
Fenk, R
Hoyer, B
Steidl, U
Kondakci, M
Graef, T
Heuk, R
Ruf, L
Strupp, C
Neumann, F
Rohr, UP
Hildebrandt, B
Haas, R
Kobbe, G
机构：
[1] Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany
[2] Harvard Univ, Inst Med, Div Hematol Oncol, Boston, MA 02115 USA
[3] Univ Dusseldorf, Dept Human Genet & Anthropol, D-40225 Dusseldorf, Germany
来源：
LEUKEMIA | 2005年 / 19卷 / 01期
关键词：
D O I：
10.1038/sj.leu.2403564
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：156 / 159
页数：5
相关论文
共 50 条
  • [1] Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma
    R Fenk
    B Hoyer
    U Steidl
    M Kondakci
    T Graef
    R Heuk
    L Ruf
    C Strupp
    F Neumann
    U-P Rohr
    B Hildebrandt
    R Haas
    G Kobbe
    Leukemia, 2005, 19 : 156 - 159
  • [2] Single agent thalidomide for treatment of first relapse following high-dose chemotherapy and autologous blood stem cell transplantation in patients with multiple myeloma.
    Hoyer, B
    Fenk, R
    Steidl, U
    Kondakci, M
    Germing, U
    Haas, R
    Kobbe, G
    BLOOD, 2003, 102 (11) : 691A - 692A
  • [3] Treatment of patients with multiple myeloma in first relapse after high-dose chemotherapy with single agent thalidomide - duration of first remission is the major prognostic factor for EFS and OS
    Hoyer, B
    Fenk, R
    Steidl, U
    Germing, U
    Haas, R
    Kobbe, G
    BONE MARROW TRANSPLANTATION, 2004, 33 : S162 - S162
  • [4] Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent
    Zomas, A
    Anagnostopoulos, N
    Dimopoulos, MA
    BONE MARROW TRANSPLANTATION, 2000, 25 (12) : 1319 - 1320
  • [5] Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent
    A Zomas
    N Anagnostopoulos
    MA Dimopoulos
    Bone Marrow Transplantation, 2000, 25 : 1319 - 1320
  • [6] Single-agent paclitaxel at first relapse following adjuvant chemotherapy for breast cancer
    Davidson, NG
    SEMINARS IN ONCOLOGY, 1995, 22 (06) : 2 - 6
  • [7] Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison
    Prince, H. Miles
    Adena, Michael
    Smith, Dell Kingsford
    Hertel, Judy
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (02) : 93 - 99
  • [8] High-dose chemotherapy in multiple myeloma
    Goldschmidt, H
    Hegenbart, U
    Wallmeier, M
    Moos, M
    Haas, R
    LEUKEMIA, 1997, 11 : S27 - S31
  • [9] High-dose chemotherapy for multiple myeloma
    不详
    AMERICAN JOURNAL OF NURSING, 2003, 103 (08) : 19 - 19
  • [10] High-dose chemotherapy for multiple myeloma
    Fermand, JP
    Ravaud, P
    PRESSE MEDICALE, 1997, 26 (11): : 521 - 524
12345